Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Feb 10;34(7):950-6.
doi: 10.1016/j.vaccine.2015.12.045. Epub 2016 Jan 7.

Immunogenicity and efficacy of alphavirus-derived replicon vaccines for respiratory syncytial virus and human metapneumovirus in nonhuman primates

John T Bates  1 , Jennifer A Pickens  1 , Jennifer E Schuster  2 , Monika Johnson  2 , Sharon J Tollefson  2 , John V Williams  3 , Nancy L Davis  4 , Robert E Johnston  5 , Nancy Schultz-Darken  6 , James C Slaughter  7 , Frances Smith-House  1 , James E Crowe Jr  8
Affiliations

Immunogenicity and efficacy of alphavirus-derived replicon vaccines for respiratory syncytial virus and human metapneumovirus in nonhuman primates

John T Bates et al. Vaccine. .

Abstract

Human respiratory syncytial virus (hRSV) and human metapneumovirus (hMPV) are major causes of illness among children, the elderly, and the immunocompromised. No vaccine has been licensed for protection against either of these viruses. We tested the ability of two Venezuelan equine encephalitis virus-based viral replicon particle (VEE-VRP) vaccines that express the hRSV or hMPV fusion (F) protein to confer protection against hRSV or hMPV in African green monkeys. Animals immunized with VEE-VRP vaccines developed RSV or MPV F-specific antibodies and serum neutralizing activity. Compared to control animals, immunized animals were better able to control viral load in the respiratory mucosa following challenge and had lower levels of viral genome in nasopharyngeal and bronchoalveolar lavage fluids. The high level of immunogenicity and protective efficacy induced by these vaccine candidates in nonhuman primates suggest that they hold promise for further development.

Keywords: Metapneumovirus; Nonhuman primates; Replicon particles; Respiratory syncytial virus; Vaccine.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Detection of hRSV in BAL (A) or nostril (B) following challenge. The level of viable RSV was measured in each compartment by direct plaque assay of samples on HEp-2 cell monolayer cultures. Plaques were visualized by immunoperoxidase staining.
Figure 2
Figure 2
Detection of RSV genome in BAL (A) or nostril (B) following challenge. Primers and probe targeting the hRSV matrix (M) gene were used to detect hRSV genome. Samples with a cycle threshold value less than 40 were considered positive.
Figure 3
Figure 3
Detection of hMPV genome in BAL (A) or nostril (B) following challenge. Primers and probe targeting the hMPV N gene were used to detect hMPV genome. Samples with a cycle threshold value less than 40 were considered positive.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Collins PLaC, JE . Field’s Virology. 5. 2007. Respiratory Syncytial Virus and Human Metapneumovirus; pp. 1601–46.
    1. Edwards KM, Zhu Y, Griffin MR, Weinberg GA, Hall CB, Szilagyi PG, et al. Burden of human metapneumovirus infection in young children. N Engl J Med. 2013;368:633–43. - PMC - PubMed
    1. Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, Singleton RJ, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet. 2010;375:1545–55. - PMC - PubMed
    1. Williams JV, Harris PA, Tollefson SJ, Halburnt-Rush LL, Pingsterhaus JM, Edwards KM, et al. Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. N Engl J Med. 2004;350:443–50. - PMC - PubMed
    1. Robertson SE, Roca A, Alonso P, Simoes EA, Kartasasmita CB, Olaleye DO, et al. Respiratory syncytial virus infection: denominator-based studies in Indonesia, Mozambique, Nigeria and South Africa. Bulletin of the World Health Organization. 2004;82:914–22. - PMC - PubMed

Publication types

MeSH terms